Taxol

Company: Bristol-Myers Squibb
Approval Status: Approved August 1997
Treatment for: Kaposi's Sarcoma
Areas: Immune System; Cancer & Oncology

| General Information |

General Information

The U.S. Food and Drug Administration approved Bristol-Myers Squibb's cancer drug Taxol for the treatment of AIDS-related Kaposi's Sarcoma. Taxol therapy reduces the size of patients' tumors and diminishes their symptoms and pain. Taxol helped a majority of patients who had failed other therapies.

< back to top

Taxol Drug Information

The Taxol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.